Matthieu Vallin

Partner at BREEGA · London, United Kingdom

Invests in AI

AI is one of the sectors on Matthieu Vallin's investor profile, next to Healthcare & Biotech and Hardware & Deep Tech, at seed, early-stage venture and Series A. The record holds 4 deals, including Awell, Ufonia and Apheris.

Email Investor

Email Investor

Credits to line up before a seed round

Matthieu Vallin backs companies at seed, early-stage venture and Series A. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Awell
  • Ufonia
  • Apheris
  • CoMind

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Hardware & Deep Tech
Rounds
Seed, Early-stage venture, Series A
Profile
Venture investor
Deals on record
4
Based in
London, United Kingdom

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Matthieu Vallin invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Matthieu Vallin's investor profile, together with Healthcare & Biotech and Hardware & Deep Tech. The stages on record are seed, early-stage venture and Series A.
Which companies has Matthieu Vallin backed?
The record lists 4 deals, including Awell, Ufonia, Apheris and CoMind. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Matthieu Vallin?
For a company raising a seed round, AI Perks lists credits such as Weaviate (up to $100,000), AI21 Labs (up to $10,000), Redis (up to $10,000) and Replit (up to $25,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor